VLKIM
SBRA icon

Van Lanschot Kempen Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-381,329
Closed -$6.66M – 255
2025
Q1 		$6.66M Buy
381,329
+121,158
+47% +$2.04M 0.07% 171
2024
Q4 		$4.51M Buy
260,171
+42,091
+19% +$769K 0.04% 183
2024
Q3 		$4.06M Sell
218,080
-345,764
-61% -$5.83M 0.04% 176
2024
Q2 		$8.68M Buy
563,844
+463,344
+461% +$6.62M 0.1% 139
2024
Q1 		$1.48M Buy
+100,500
New +$1.39M 0.02% 188
2023
Q3 		– Sell
-30,100
Closed -$354K – 212
2023
Q2 		$354K Sell
30,100
-62,100
-67% -$707K 0.01% 186
2023
Q1 		$1.06M Buy
92,200
+69,400
+304% +$859K 0.02% 185
2022
Q4 		$283K Sell
22,800
-323,200
-93% -$4.12M 0.01% 174
2022
Q3 		$4.54M Buy
+346,000
New +$5.11M 0.18% 105
2021
Q3 		– Sell
-615,000
Closed -$11.2M – 219
2021
Q2 		$11.2M Buy
615,000
+555,150
+928% +$9.88M 0.4% 81
2021
Q1 		$1.04M Buy
+59,850
New +$1.05M 0.05% 145

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Van Lanschot Kempen Investment Management's SBRA Position: Q2 2025 in Review

Van Lanschot Kempen Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 381,329 shares — an estimated $6.66M sold.

Van Lanschot Kempen Investment Management first reported a position in SBRA in Q1 2021 and held it in 11 quarters. The position peaked at $11.2M in Q2 2021. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Van Lanschot Kempen Investment Management reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 381,329 Sabra Healthcare REIT shares in Q2 2025, an estimated $6.66M.
  • Van Lanschot Kempen Investment Management first reported a position in Sabra Healthcare REIT in Q1 2021 and held it in 11 quarters.
  • Van Lanschot Kempen Investment Management's Sabra Healthcare REIT position peaked at $11.2M in Q2 2021.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.